mibefradil has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, M; Lu, B; Ma, H; Wang, H; Wang, P; Yu, W; Yulin, Z; Zhang, G | 1 |
| Crameri, FM; Eichler, DA; Lenz, B; Schläppi, B; Seymour, RA; Wiltshire, HR; Wood, J | 1 |
2 other study(ies) available for mibefradil and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Suppression of T-type Ca2+ channels inhibited human laryngeal squamous cell carcinoma cell proliferation running title: roles of T-type Ca2+ channels in LSCC cell proliferation.
Topics: Calcium Channel Blockers; Calcium Channels, T-Type; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Laryngeal Neoplasms; Mibefradil; RNA, Small Interfering | 2014 |
Modulation of oral squamous cell carcinoma incidence in rats via diet and a novel calcium channel antagonist.
Topics: Administration, Oral; Animals; Calcium Channel Blockers; Calcium Channels; Carcinoma, Squamous Cell; Diet; Dose-Response Relationship, Drug; Female; Male; Mibefradil; Molecular Structure; Mouth Neoplasms; Rats; Rats, Wistar; Toxicity Tests, Chronic | 2005 |